Early Intranasal Insulin Therapy Halts Progression of Neurodegeneration: Progress in Alzheimer’s Disease Therapeutics

Aging Health
doi 10.2217/ahe.11.89
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Therapeutics of Neurotransmitters in Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2017English

Biomarkers for the Early Detection and Progression of Alzheimer’s Disease

Neurotherapeutics
NeurologyPharmacology
2016English

Diffusion Imaging Changes in Grey Matter in Alzheimer’s Disease: A Potential Marker of Early Neurodegeneration

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2015English

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

Archives of Neurology
2012English

Neonatal Neurodegeneration in Alzheimer’s Disease Transgenic Mouse Model

Journal of Alzheimer's Disease Reports
2018English

Neuroinflammation and Insulin Resistance in Alzheimer’s Disease

Siberian Medical Review
2014English

Hierarchical Porous Carbon—PLLA and PLGA Hybrid Nanoparticles for Intranasal Delivery of Galantamine for Alzheimer’s Disease Therapy

Pharmaceutics
Pharmaceutical Science
2020English

Amygdalar Atrophy in Early Alzheimer’s Disease

Current Alzheimer Research
Neurology
2014English

Blood Amyloid-Β Oligomerization Associated With Neurodegeneration of Alzheimer’s Disease

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy